BHG Executive and Leadership Team

Charles Panicker, the Chief Revenue Officer at BHG, directs all revenue-generating activities and financial growth strategies. Panicker oversees the sales and marketing departments, ensuring alignment with the company's mission to expand access to opioid use disorder (OUD) treatment across the United States. This leadership role involves developing and executing innovative revenue models that support the scaling of BHG's network of Joint Commission-accredited outpatient centers. By optimizing pricing structures and identifying new market opportunities, Charles Panicker directly contributes to the financial stability and operational capacity of the organization. The Chief Revenue Officer's focus remains on maximizing patient reach and ensuring the long-term sustainability of BHG's critical services.

Paul Di Vincenzo, the Chief Technology Officer at BHG, architects and executes the company's technology vision and infrastructure. Di Vincenzo leads the IT and data analytics teams, ensuring the secure and efficient operation of all digital platforms that support patient care and operational management. This critical role involves implementing advanced technological solutions to enhance the delivery of evidence-based medical and behavioral therapies for individuals with opioid use disorder (OUD). By driving innovation in telehealth and data security, Paul Di Vincenzo strengthens BHG's position as the largest network of Joint Commission-accredited outpatient opioid treatment centers. The Chief Technology Officer's strategic initiatives ensure technological scalability and compliance with healthcare regulations, directly impacting patient outcomes and operational excellence.

Russell Goin, the Chief People Officer at BHG, directs all human capital strategies and organizational development initiatives. Goin oversees talent acquisition, employee engagement, and culture cultivation across BHG's extensive network of outpatient opioid treatment and recovery centers. This leadership position is vital for attracting and retaining top clinical and administrative talent, essential for delivering comprehensive, personalized evidence-based therapies for individuals with opioid use disorder (OUD). By fostering a supportive and high-performance work environment, Russell Goin ensures that BHG's dedicated staff are equipped to provide exceptional patient care. The Chief People Officer's efforts are fundamental to maintaining BHG's status as the largest network of Joint Commission-accredited centers, driving operational success through its people.

Benjamin Nordstrom, the Chief Medical Officer at BHG, guides the clinical strategy and ensures the highest standards of patient care across the organization. Nordstrom oversees the development and implementation of evidence-based medical and behavioral therapies for individuals with opioid use disorder (OUD), maintaining BHG's commitment to quality and efficacy. This pivotal role involves leading the clinical teams, ensuring adherence to Joint Commission accreditation standards, and driving advancements in treatment protocols. By championing clinical excellence, Benjamin Nordstrom directly enhances the effectiveness of BHG's services, reinforcing its position as the largest network of outpatient opioid treatment and recovery centers in the U.S. The Chief Medical Officer's expertise is crucial for patient outcomes and the continuous improvement of treatment methodologies.